Related Experiment Video
Updated: May 11, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER)
Jarod P McAteer1, Jorge A Huaco, Kenneth W Gow
1Pediatric General and Thoracic Surgery, Seattle Children's Hospital and University of Washington, Seattle, WA 98105, USA. jarodmc@uw.edu
Insights
Pediatric adrenocortical carcinoma (ACC) is rare. Children aged 4 years or younger had significantly better outcomes and survival rates compared to older children with ACC.
Area of Science:
- Pediatric Oncology
- Cancer Epidemiology
- Clinical Research
Background:
- Adrenocortical carcinoma (ACC) is a rare malignancy in children, with varying global incidence rates.
- Limited data exists on pediatric ACC, necessitating further investigation into incidence and prognosis.
Purpose of the Study:
- To determine national incidence rates of pediatric adrenocortical carcinoma (ACC).
- To identify independent prognostic indicators for children diagnosed with ACC.
Main Methods:
- Utilized the SEER database (1973-2008) to identify pediatric patients (<20 years) with ACC.
- Analyzed incidence rates and survival data, considering clinical and demographic factors.
- Employed Cox proportional-hazards regression to identify predictors of disease-specific survival.
Main Results:
- Identified 85 pediatric ACC cases; annual incidence was 0.21 per million.
- Younger patients (≤4 years) presented with more favorable features: localized disease (76% vs. 31%) and smaller tumors (<10 cm, 69% vs. 31%).
- Younger age (≤4 years) and localized disease were significant predictors of better survival; age remained significant after adjustment for tumor size.
Conclusions:
- This study is one of the largest reviews of pediatric adrenocortical carcinoma (ACC).
- Diagnosis at age 4 years or younger is associated with a significantly better prognosis.
- Patient and tumor-related factors likely contribute to the improved outcomes observed in younger children.
Background:
Adrenocortical carcinoma (ACC) is rarely described in children. There is variation in incidence worldwide. This study sought to identify national incidence rates and independent prognostic indicators for children.
Methods:
The SEER database was queried for the years 1973 through 2008 for all patients with ACC less than 20 years of age. Incidence rates and survival were analyzed accounting for clinical and demographic factors. Cox proportional-hazards regression was used to identify factors associated with disease-specific survival.
Results:
Eighty-five patients (57 F: 28 M) were identified. Annual ACC incidence was 0.21 per million. Young patients (≤ 4 years) were noted to have more favorable features than older patients (5-19 years) and more likely to have local disease (76% vs. 31%, p < 0.001), tumor size < 10 cm (69% vs. 31%, p = 0.007), and better 5-year survival (91.1% vs. 29.8%, p < 0.001). After adjustment, the most significant predictors of cancer-specific death were age 5-19 years (HR 8.6, p = 0.001) and distant disease (HR 3.3, p = 0.01). After accounting for tumor size, only age maintained statistical significance (HR 9.9, p = 0.009).
Conclusions:
Our study represents one of the largest reviews of pediatric ACC. An age of ≤ 4 years was associated with better outcome. Potential factors responsible for this include patient and tumor related factors.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Assumptions of Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...